Autres langues Lincoln Pharmaceuticals Limited

Actions

LINCOLN

INE405C01035

Marché Fermé - Bombay S.E. Autres places de cotation 12:00:48 30/04/2024			Varia. 5j.	Varia. 1 janv.
604,6 ^INR	+1,67 %		+2,01 %	-0,74 %

30/03	Lincoln Pharmaceuticals Limited annonce que Pirabhai Suthar cessera d'être un administrateur indépendant	CI
22/02	Lincoln Pharmaceuticals Limited annonce la démission de Meha Patel en tant qu'administratrice indépendante non exécutive	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Lincoln Pharmaceuticals Limited Announces Pirabhai Suthar Will Cease to Be an Independent Director	30/03
Lincoln Pharmaceuticals Limited Announces Resignation of Meha Patel as Non-Executive Independent women Director	22/02
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08/02
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	02/11
Lincoln Pharmaceuticals Limited Declares Dividend for the Financial Year 2022-23	30/09/23
Lincoln Pharmaceuticals Limited Proposes Dividend for the Financial Year 2022-2023	06/09/23
Lincoln Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	10/08/23
Lincoln Pharmaceuticals Limited Recommends A Dividend for the Year Ended March 31, 2023	25/05/23
Lincoln Pharmaceuticals Limited Approves the Resignation of Anand A. Patel from the Position of Whole Time Director as Well as Director of the Company	25/05/23
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	25/05/23
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	09/02/23
Lincoln Pharmaceuticals Limited Informs About Demise of Shri Ishwarlal Ambalal Patel Independent Director	05/12/22
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	10/11/22
Lincoln Pharmaceuticals Limited Appoints Trusha Shah as Company Secretary and Compliance Officer	10/11/22
Lincoln Pharmaceuticals Limited Approves to Declare Dividend for the Financial Year 2021-22	30/09/22
Lincoln Pharmaceuticals Limited Proposes to Declare Dividend for the Financial Year 2021-2022	06/09/22
Lincoln Pharmaceuticals Limited Approves Appointment of Anand A. Patel as an Additional and Whole Time Director	09/08/22
Lincoln Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	09/08/22
Lincoln Pharmaceuticals Limited Announces Resignation of Niren A. Desai as Company Secretary / Compliance Officer, with Effect from July 19, 2022	20/07/22
Lincoln Pharmaceuticals : Newspaper Advertisements	20/05/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Lincoln Pharmaceuticals Limited

Actions

LINCOLN

INE405C01035

Autres langues

Filtres